New weapon against superbugs: Real-World test begins
NCT ID NCT07176247
Summary
This study aims to see how well a new antibiotic combination (aztreonam-avibactam) works in real hospital settings for patients with serious infections caused by bacteria that resist most other drugs. It will track about 100 patients in intensive care or infectious disease units, looking at whether their infections clear up and how they recover. The goal is to gather evidence to help doctors use this new treatment more effectively against these dangerous infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL CARE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
French Society of Intensive Care (SRLF)
Paris, France
Conditions
Explore the condition pages connected to this study.